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Abstract
Introduction of the model of iodine prophylaxis based on the consumption of iodized salt in 1997 has eliminated
the iodine deficiency in Poland. However, in accordance with the current recommendations, all women who are
planning to be pregnant or are pregnant or breastfeeding should receive an additional dose of iodine at 150–200
mcg / day because of the increased body's need for iodine during this period. Studies show that only part of
women in Poland conduct a proper iodine prophylaxis and it is often initiated in the second and third trimester of
pregnancy. The authors try to analyze the possible causes of this situation, pointing out what could be done to
increase the degree of compliance with iodine prophylaxis during pregnancy and physiological lactation in Poland.
Keywords: Iodine prophylaxis, Pregnant and breast-feeding women, Iodine deficiency
Background
Introduction of the model of iodine prophylaxis based
on the consumption of iodized salt in 1997, which is still
in force today, was one of the undisputed successes of
health policy in Poland after the change of the economic
system.
Before that, Poland, like many countries in Europe,
was an example of a country lying on endemic area of a
goitre of a moderate or mild degree and prevalence of
goitre among schoolchildren was approximately 35 %.
After the introduction of iodine prophylaxis prevalence
of goitre decreased significantly and equaled approxi-
mately 1.5 %. The value of ioduria increased signifi-
cantly, as well [1].
Data on the effectiveness of the conducted prophylaxis
are so numerous that a wide group of doctors and the
public got the message that the problem of iodine
deficiency in Poland has finally been resolved. That is
true, but it should be remembered that iodine intake in
the population is variable and depends on many factors
and it can not be ruled out that the problem of iodine
deficiency will reappear in the future.
The phenomenon of re-emergence of iodine deficiency
has been described, e.g. in Australia, where the
introduction of iodine prophylaxis had solved the prob-
lem of iodine deficiency, but after some time the endem-
icity of goitre developed again [2].
Currently, the ioduria oscillates around the border
values (they only slightly exceeds the threshold value
considered to be sufficient), and in such situation the
constraints on the consumption of salt can result in in-
sufficient iodine intake. It is probable because Poland is
taking multiple approaches to reduce the intake of salt,
which is relatively large, and responsible, among others,
for the development of hypertension and cardiovascular
events. These actions aim at reducing salt intake in
Poland to 5–6 g/day [3].
Because of this, the novel carrier of iodine are being
introduced, in order to diversify the source of this elem-
ent in the situation of less salt consumption. On the
market there are available drinking waters either con-
taining iodine naturally or enriched with iodine in the
production process, iodine is added to animal feed, and
thus milk and meat are enriched with iodine. Iodine sup-
plementation can also be performed using complex or
simple pharmacological preparations containing iodine.
Iodine and pregnancy
Iodine prophylaxis carried out on the basis of iodization
of salt in Poland - is effective so far, but it does not meet
the increased demand for iodine in pregnant and breast-
feeding women.
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Therefore, in accordance with the recommendations
of Polish Society of Endocrinology, pregnant and breast-
feeding women should take an extra supplementation of
iodine in dose of 150–200 mcg/day [in the form of
multivitamin or simple preparation of potassium iodide
(KI)] [4]. It is also suggested that such supplementation
should start already in the preconceptional period [4–6]
while another recommendation [7] even advocates that
all women who are planning to be pregnant should take
an extra supplementation of iodine. Women frequently
ask how long this supplementation should precede the
moment of becoming pregnant - it depends on the de-
gree of iodine deficiency; in Polish reality, while in the
general population the intake of iodine is practically cor-
rect, it should be considered that such supplementation
is only meant to minimize the risk of iodine deficiency
and can be used for a relatively short time, ie. 1–2
months (in cases of suspected significant iodine defi-
ciency these indications may differ). Any excess of iodine
is excreted by kidneys, so when giving the inorganic iod-
ine in microgram dose, the risk of accumulation of
iodine in the body practically does not exist.
Compliance with recommendations of iodine prophylaxis
Even the best recommendations are effective only if they
are respected. In our study, we saw that only 45 % of
women takes the recommended dose of iodine; conse-
quently ioduria in pregnant women is significantly low,
indirectly proving that the supply of iodine in this group
is insufficient. These data are consistent with the obser-
vations of other authors - too few pregnant women in
Poland takes additional iodine supplementation [8].
We have also noticed that iodine prophylaxis is being
introduced too late (in the second or third trimester of
pregnancy). None of the women in our survey took iod-
ine in the preconceptional period or in the first trimester
of pregnancy.
The explanation for this situation may be the fact that
many obstetricians/gynecologists starts the vitamin sup-
plementation in advanced pregnancy, trying to ensure
due supply of vitamins and minerals at the beginning of
pregnancy only through proper diet. Here it is worth
once again to recall that in such a situation suplementa-
tion of iodine can be carried out by giving a simple prep-
aration of potassium iodide, remembering that it can
only be obtained with prescription. In the group of
women studied by us, none took KI, they took only
vitamins, which suggest that this form of iodine supple-
mentation is being ignored.
The multitude of available multivitamin, registered ei-
ther as a drug or as a dietary supplement, also forces the
recommendation of a preparation containing iodine. This
is not only connected with the credibility of the product -
as evidenced by studies, only in a small number of cases,
the actual iodine content in the preparation is consistent
with the amount declared by the manufacturer; most often
these values differ significantly, at least +/− 20 % and
more. The second issue to keep in mind is that not all the
multivitamin supplements prepared for pregnant women
contain iodine. So if a woman will not be indicated a
proper preparation, there is a risk that at the pharmacy
she will acquire a preparation that does not contain suffi-
cient dose of iodine.
The knowledge about the consequences of a signifi-
cant iodine deficiency in pregnant women is very wide.
Much less information is available on the slight iodine
deficiency. Capturing of such dependence is difficult due
to methodological problems.
The current tools being at our disposal allow us to
effectively eliminate the potential iodine deficiency in
pregnant women and, therefore, eliminate all the conse-
quences of iodine deficiency, even of a slight degree. We
should implement the conclusions of the present studies
into everyday medical practice.
Conclusions
The existing model of iodine prophylaxis in Poland has
proved its efficiency and has eliminated endemicity of
goitre in Poland.
Supply of iodine varies with time and in the future, due
to the tendency to limit salt intake, it may decrease again
and become insufficient. The needs of women during
pregnancy and physiological lactation are so great that the
amount of iodine supplied by a common model of iodine
prophylaxis is insufficient; these women should receive
additional iodine supplementation at a dose of 150–200
mcg / day. Only part of the pregnant women in Poland re-
ceive proper iodine supplementation and it rarely begins
during the preconceptional period or in early pregnancy.
In order to ensure appropriate dose of iodine, one should
carefully, depending on individual needs, select a iodine-
containing preparation.
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